Cargando…

Clinicopathological characteristics of endometrial carcinomas according to DNA mismatch repair protein status

DNA mismatch repair protein deficiency (MMRd) in endometrial carcinoma is associated with the risk of Lynch syndrome and response to immune checkpoint inhibitors. It is also related to microsatellite instability and corresponds to a molecular subtype of endometrial tumor with an unclear prognosis. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Freitas, Daniela, Aguiar, Fernando Nalesso, Anton, Cristina, de Almeida, Danielle Cristina, Bacchi, Carlos Eduardo, Carvalho, Jesus Paula, Carvalho, Filomena Marino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319187/ https://www.ncbi.nlm.nih.gov/pubmed/37408903 http://dx.doi.org/10.1016/j.heliyon.2023.e17495

Ejemplares similares

L1 Cell Adhesion Molecule (L1CAM) expression in endometrioid endometrial carcinomas: A possible pre-operative surrogate of lymph vascular space invasion
por: de Freitas, Daniela, et al.
Publicado: (2018)

Clinicopathologic features of endometrial cancer with mismatch repair deficiency
por: Gordhandas, Sushmita, et al.
Publicado: (2020)

Surgical treatment of endometrial cancer in developing countries: reasons to consider systematic two-step surgical treatment
por: Anton, Cristina, et al.
Publicado: (2015)

Association between intratumoral lymphatic microvessel density (LMVD) and clinicopathologic features in endometrial cancer: a retrospective cohort study
por: Kawamura, Lecy, et al.
Publicado: (2010)

Mismatch repair deficiency and clinicopathological characteristics in endometrial carcinoma: a systematic review and meta-analysis
por: Jumaah, Alaa Salah, et al.
Publicado: (2021)

Diffusion-weighted magnetic resonance imaging to detect synchronous uterine endometrial and endocervical adenocarcinoma
por: Carvalho, Jesus Paul, et al.
Publicado: (2012)

An Analysis of Clinical, Surgical, Pathological and Molecular Characteristics of Endometrial Cancer According to Mismatch Repair Status. A Multidisciplinary Approach
por: Dondi, Giulia, et al.
Publicado: (2020)

Long-Term Survival and Clinicopathological Implications of DNA Mismatch Repair Status in Endometrioid Endometrial Cancers in Hong Kong Chinese Women
por: Lee, Jacqueline Ho Sze, et al.
Publicado: (2021)

Complete Clinical Response in Stage IVB Endometrioid Endometrial Carcinoma after First-Line Pembrolizumab Therapy: Report of a Case with Isolated Loss of PMS2 Protein
por: Carvalho, Jesus Paula, et al.
Publicado: (2020)

Ten years of experience with endometrial cancer treatment in a single Brazilian institution: Patient characteristics and outcomes
por: Anton, Cristina, et al.
Publicado: (2020)

Relationship between DNA Mismatch Repair Deficiency and Endometrial Cancer
por: Masuda, Kenta, et al.
Publicado: (2011)

Comparison of Methods for Testing Mismatch Repair Status in Endometrial Cancer
por: Mendiola, Marta, et al.
Publicado: (2023)

Clinical treatment of vulvar Paget's disease: a case report
por: Anton, Cristina, et al.
Publicado: (2011)

Risk for Hereditary Neoplastic Syndromes in Women with Mismatch Repair-Proficient Endometrial Cancer
por: dos Santos, Jennifer Thalita Targino, et al.
Publicado: (2023)

Clinicopathologic Factors Associated with Mismatch Repair Status Among Filipino Patients with Young-Onset Colorectal Cancer
por: Sacdalan, Dennis Lee, et al.
Publicado: (2021)

Mismatch repair and clinical response to immune checkpoint inhibitors in endometrial cancer
por: Antill, Yoland, et al.
Publicado: (2021)

Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer
por: Post, Cathalijne C B, et al.
Publicado: (2021)

Mismatch repair genes expression defects & association with clinicopathological characteristics in colorectal carcinoma
por: Kaur, Gurjeet, et al.
Publicado: (2011)

DNA Mismatch Repair Gene Variant Classification: Evaluating the Utility of Somatic Mutations and Mismatch Repair Deficient Colonic Crypts and Endometrial Glands
por: Walker, Romy, et al.
Publicado: (2023)

The role of intratumoral lymphovascular density in distinguishing primary from secondary mucinous ovarian tumors
por: de Lacerda Almeida, Bernardo Gomes, et al.
Publicado: (2014)

A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses
por: Anton, Cristina, et al.
Publicado: (2012)

Introduction of robotic surgery for endometrial cancer into a Brazilian cancer service: a randomized trial evaluating perioperative clinical outcomes and costs
por: Silva, Alexandre Silva e, et al.
Publicado: (2018)

Clinical significance of mismatch repair genes immunohistochemical expression of complex endometrial hyperplasia
por: Han, Su Jin, et al.
Publicado: (2015)

Targeted sequencing of genes associated with the mismatch repair pathway in patients with endometrial cancer
por: Singh, Ashish Kumar, et al.
Publicado: (2020)

Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer
por: Fountzilas, Elena, et al.
Publicado: (2019)

Mismatch Repair Universal Screening of Endometrial Cancers (MUSE) in a Canadian Cohort
por: Lawrence, Jessica, et al.
Publicado: (2021)

Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations
por: Li, Wenbin, et al.
Publicado: (2015)

DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers
por: Kato, Masafumi, et al.
Publicado: (2015)

Distinct Immunological Landscapes Characterize Inherited and Sporadic Mismatch Repair Deficient Endometrial Cancer
por: Ramchander, Neal C., et al.
Publicado: (2020)

Histological and Somatic Mutational Profiles of Mismatch Repair Deficient Endometrial Tumours of Different Aetiologies
por: Ryan, Neil A. J., et al.
Publicado: (2021)

Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Molecularly Classified Endometrial Carcinoma
por: Loukovaara, Mikko, et al.
Publicado: (2021)

Lost opportunities for mismatch repair (MMR) screening among minority women with endometrial cancer
por: Huang, Marilyn, et al.
Publicado: (2021)

Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer
por: Konstantinopoulos, Panagiotis A., et al.
Publicado: (2022)

Immune Checkpoint Inhibitors and Mismatch Repair Status in Advanced Endometrial Cancer: Elective Affinities
por: Rizzo, Alessandro
Publicado: (2022)

The Role of Immunohistochemistry Markers in Endometrial Cancer with Mismatch Repair Deficiency: A Systematic Review
por: Favier, Amelia, et al.
Publicado: (2022)

Screening of Lynch syndrome in endometrial cancer in Iranian population with mismatch repair protein by immunohistochemistry
por: Noei Teymoordash, Somayyeh, et al.
Publicado: (2022)

Expression of Programmed Cell Death Ligand-1 and Mismatch Repair Status in Endometrial Carcinomas
por: Rajendran, Madhubala, et al.
Publicado: (2023)

Clinicopathological characteristics and loss of mismatch repair protein expression in Chinese upper tract urothelial carcinomas
por: Shang, Zhi, et al.
Publicado: (2022)

Ovarian Cancer Previvors: How to manage these patients?
por: Carvalho, Jesus Paula, et al.
Publicado: (2019)

Mismatch repair deficiency and aberrations in the Notch and Hedgehog pathways are of prognostic value in patients with endometrial cancer
por: Polychronidou, Genovefa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hel3knmpstnjite785tp16ohbb